Welcome to Optimal Antithrombotic Care for Patients with Acute Coronary Syndromes: Across the Continuum of Unstable Angina, NSTEMI, and STEMI. This CME-certified activity is intended for interventional cardiologists, ER physicians, and allied health professionals who treat patients with acute coronary syndromes (ACS). It will be presented live at selected hospitals throughout the US during mid-2011 and early 2012. Click on the Calendar of Live Events to see if this program is coming to a hospital near you. You can also view this important online program on-demand and receive CME credit. Click on the link below to access the full, online program.
Although dual antiplatelet therapy is well documented to reduce ischemic complications in patients with ACS, it is underused within the first 24 hours after hospitalization. This puts ACS patients at greater risk of atherothrombotic complications, including death. Newly approved and emerging antiplatelet agents promise to improve clinical outcomes of ACS patients. However, a gap exists between current practice in the acute management of ACS patients, and the level of physician understanding of new and emerging therapies that have the potential to improve patient outcomes. Physicians who treat ACS patients need to keep abreast of the latest clinical trial results and incorporate these insights into their clinical practices to provide optimum management of ACS patients.